FGEN Annual EBITDA
-$261.40 M
+$21.42 M+7.57%
31 December 2023
Summary:
As of January 20, 2025, FGEN annual earnings before interest, taxes, depreciation & amortization is -$261.40 million, with the most recent change of +$21.42 million (+7.57%) on December 31, 2023. During the last 3 years, it has fallen by -$97.13 million (-59.12%). FGEN annual EBITDA is now -31108.90% below its all-time high of $843.00 thousand, reached on December 31, 2013.FGEN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FGEN Quarterly EBITDA
-$12.24 M
-$2.10 M-20.70%
30 September 2024
Summary:
As of January 20, 2025, FGEN quarterly earnings before interest, taxes, depreciation & amortization is -$12.24 million, with the most recent change of -$2.10 million (-20.70%) on September 30, 2024. Over the past year, it has increased by +$37.59 million (+75.44%). FGEN quarterly EBITDA is now -110.01% below its all-time high of $122.29 million, reached on June 30, 2019.FGEN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FGEN TTM EBITDA
-$99.87 M
+$44.57 M+30.86%
30 September 2024
Summary:
As of January 20, 2025, FGEN TTM earnings before interest, taxes, depreciation & amortization is -$99.87 million, with the most recent change of +$44.57 million (+30.86%) on September 30, 2024. Over the past year, it has increased by +$161.53 million (+61.79%). FGEN TTM EBITDA is now -241.83% below its all-time high of $70.42 million, reached on June 30, 2019.FGEN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FGEN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.6% | +75.4% | +61.8% |
| 3 y3 years | -59.1% | +75.4% | +61.8% |
| 5 y5 years | -281.3% | +75.4% | +61.8% |
FGEN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.6% | -20.7% | +90.8% | at high | +71.7% |
| 5 y | 5-year | -399.7% | +7.6% | -122.8% | +90.8% | -90.9% | +71.7% |
| alltime | all time | <-9999.0% | +7.6% | -110.0% | +90.8% | -241.8% | +71.7% |
FibroGen EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.24 M(+20.7%) | -$99.87 M(-30.9%) |
| June 2024 | - | -$10.14 M(-63.4%) | -$144.44 M(-33.4%) |
| Mar 2024 | - | -$27.67 M(-44.5%) | -$216.99 M(-17.0%) |
| Dec 2023 | -$261.40 M(-7.6%) | -$49.82 M(-12.3%) | -$261.41 M(-4.6%) |
| Sept 2023 | - | -$56.81 M(-31.3%) | -$274.12 M(-10.6%) |
| June 2023 | - | -$82.68 M(+14.7%) | -$306.49 M(+4.2%) |
| Mar 2023 | - | -$72.09 M(+15.3%) | -$294.18 M(+4.1%) |
| Dec 2022 | -$282.82 M(+3.3%) | -$62.54 M(-29.9%) | -$282.50 M(-19.9%) |
| Sept 2022 | - | -$89.18 M(+26.7%) | -$352.62 M(+68.0%) |
| June 2022 | - | -$70.37 M(+16.5%) | -$209.88 M(-22.0%) |
| Mar 2022 | - | -$60.41 M(-54.5%) | -$269.04 M(-1.7%) |
| Dec 2021 | -$273.72 M(+66.6%) | -$132.66 M(-347.7%) | -$273.72 M(+41.6%) |
| Sept 2021 | - | $53.56 M(-141.4%) | -$193.31 M(-6.8%) |
| June 2021 | - | -$129.54 M(+99.0%) | -$207.49 M(+32.2%) |
| Mar 2021 | - | -$65.09 M(+24.6%) | -$156.92 M(-4.5%) |
| Dec 2020 | -$164.28 M(+214.0%) | -$52.25 M(-232.7%) | -$164.28 M(-19.6%) |
| Sept 2020 | - | $39.38 M(-149.9%) | -$204.40 M(-28.7%) |
| June 2020 | - | -$78.97 M(+9.0%) | -$286.67 M(+235.7%) |
| Mar 2020 | - | -$72.45 M(-21.6%) | -$85.41 M(+63.3%) |
| Dec 2019 | -$52.31 M(-23.7%) | -$92.36 M(+115.4%) | -$52.31 M(-179.7%) |
| Sept 2019 | - | -$42.89 M(-135.1%) | $65.61 M(-6.8%) |
| June 2019 | - | $122.29 M(-410.8%) | $70.42 M(-199.3%) |
| Mar 2019 | - | -$39.35 M(-254.0%) | -$70.91 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$68.56 M(-34.5%) | $25.56 M(-167.1%) | -$68.56 M(-44.9%) |
| Sept 2018 | - | -$38.08 M(+100.1%) | -$124.54 M(+16.9%) |
| June 2018 | - | -$19.03 M(-48.6%) | -$106.58 M(-7.4%) |
| Mar 2018 | - | -$37.01 M(+21.7%) | -$115.11 M(+9.9%) |
| Dec 2017 | -$104.75 M(+153.2%) | -$30.42 M(+51.2%) | -$104.75 M(+4.5%) |
| Sept 2017 | - | -$20.12 M(-27.0%) | -$100.26 M(+0.4%) |
| June 2017 | - | -$27.56 M(+3.4%) | -$99.86 M(+126.2%) |
| Mar 2017 | - | -$26.65 M(+2.8%) | -$44.16 M(+6.7%) |
| Dec 2016 | -$41.37 M(-39.9%) | -$25.93 M(+31.5%) | -$41.38 M(-33.6%) |
| Sept 2016 | - | -$19.72 M(-170.1%) | -$62.32 M(-25.4%) |
| June 2016 | - | $28.15 M(-217.9%) | -$83.48 M(+66.3%) |
| Mar 2016 | - | -$23.87 M(-49.1%) | -$50.20 M(-27.1%) |
| Dec 2015 | -$68.83 M(+56.7%) | -$46.87 M(+14.6%) | -$68.83 M(+0.6%) |
| Sept 2015 | - | -$40.89 M(-166.6%) | -$68.44 M(+8.9%) |
| June 2015 | - | $61.43 M(-244.6%) | -$62.87 M(-14.8%) |
| Mar 2015 | - | -$42.49 M(-8.6%) | -$73.82 M(+68.0%) |
| Dec 2014 | -$43.93 M(-5310.7%) | -$46.49 M(+31.6%) | -$43.93 M(+115.8%) |
| Sept 2014 | - | -$35.33 M(-170.0%) | -$20.35 M(-134.9%) |
| June 2014 | - | $50.49 M(-500.6%) | $58.26 M(+649.3%) |
| Mar 2014 | - | -$12.60 M(-45.0%) | $7.78 M(-61.8%) |
| Dec 2013 | $843.00 K(-104.9%) | -$22.91 M(-152.9%) | $20.38 M(-52.9%) |
| Sept 2013 | - | $43.29 M | $43.29 M |
| Dec 2012 | -$17.05 M | - | - |
FAQ
- What is FibroGen annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for FibroGen?
- What is FibroGen annual EBITDA year-on-year change?
- What is FibroGen quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for FibroGen?
- What is FibroGen quarterly EBITDA year-on-year change?
- What is FibroGen TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for FibroGen?
- What is FibroGen TTM EBITDA year-on-year change?
What is FibroGen annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of FGEN is -$261.40 M
What is the all time high annual EBITDA for FibroGen?
FibroGen all-time high annual earnings before interest, taxes, depreciation & amortization is $843.00 K
What is FibroGen annual EBITDA year-on-year change?
Over the past year, FGEN annual earnings before interest, taxes, depreciation & amortization has changed by +$21.42 M (+7.57%)
What is FibroGen quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of FGEN is -$12.24 M
What is the all time high quarterly EBITDA for FibroGen?
FibroGen all-time high quarterly earnings before interest, taxes, depreciation & amortization is $122.29 M
What is FibroGen quarterly EBITDA year-on-year change?
Over the past year, FGEN quarterly earnings before interest, taxes, depreciation & amortization has changed by +$37.59 M (+75.44%)
What is FibroGen TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of FGEN is -$99.87 M
What is the all time high TTM EBITDA for FibroGen?
FibroGen all-time high TTM earnings before interest, taxes, depreciation & amortization is $70.42 M
What is FibroGen TTM EBITDA year-on-year change?
Over the past year, FGEN TTM earnings before interest, taxes, depreciation & amortization has changed by +$161.53 M (+61.79%)